Showing results (131-140 of 296) with videos related to

Sort By:
Pageof 30
Nature Communications|July 14, 2025
Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trialChristoph Ryffel, Jonas Lanz, Nicole Guntli, et al.
Journal of the American College of Cardiology|February 1, 2023
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac ArrestAlessandro Spirito, Lukas Vaisnora, Athanasios Papadis, et al.
JACC. Cardiovascular Interventions|March 17, 2021
Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI TrialThomas Pilgrim, Olivier Muller, Dik Heg, et al.
Circulation|July 28, 2016
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesDavid Nanchen, Baris Gencer, Olivier Muller, et al.
European Heart Journal. Acute Cardiovascular Care|June 5, 2018
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
Journal of the American Heart Association|September 27, 2015
Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationStefan Stortecky, Giulio G Stefanini, Thomas Pilgrim, et al.
Circulation. Cardiovascular Interventions|June 6, 2015
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trialAnna Franzone, Thomas Pilgrim, Dik Heg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
Lancet (London, England)|October 28, 2023
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trialJuan F Iglesias, Marco Roffi, Sylvain Losdat, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVRDaniel Malebranche, Joanna Bartkowiak, Christoph Ryffel, et al.
Pageof 30